March 22, 2016 / 12:13 AM / a year ago

Sequoia Fund sold 1.5 mln Valeant shares - WSJ

2 Min Read

March 21 (Reuters) - Valeant Pharmaceuticals International Inc's largest stakeholder, Sequoia Fund, said it sold about 1.5 million shares of the company's stock last week, the Wall Street Journal reported on Monday.

Ruane, Cunniff & Goldfarb Inc, which runs Sequoia, told the Journal that the Valeant shares were sold to reduce investor taxes by booking capital losses. (on.wsj.com/1UzKtVx)

The shares were bought in October, Ruane, Cunniff & Goldfarb's executive vice president, David Poppe, told the Journal.

In January, Ruane, Cunniff & Goldfarb, long known for its ties to Warren Buffett, was sued by shareholders who claimed it recklessly took a huge stake in the embattled drug company Valeant, causing more than $2 billion in losses.

Valeant, a target of a securities investigation and under scrutiny for its pricing and accounting practices, said on Monday that its longtime chief executive officer was leaving just three weeks after returning from a medical leave.

Ruane, Cunniff could not immediately be reached outside of regular business hours.

Reporting by Amrutha Penumudi in Bengaluru; Editing by Matthew Lewis

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below